Skip to main content

Advertisement

Table 1 Baseline characteristics of the study population (n = 137)

From: Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease

Characteristics  
Age (years) 63.1 ± 7.9
Sex (male/female) 115/ 22
Ethnicity (Caucasian/non-Caucasian) 114/ 23
BMI (kg/m2) 29.2 ± 5.0
Waist circumference (cm) 106 ± 13
Systolic blood pressure (mmHg) 139 ± 17
Diastolic blood pressure (mmHg) 79 ± 9
Metabolic syndrome¤ 105 (77%)
Albuminuria (incl. micro-) 34 (25%)
Current smoker 23 (17%)
Previous myocardial infarction 62 (45%)
Hypertension 100 (73%)
Years of diabetes* 9 (5, 15)
Creatinine (μmol/L)* 79 (68, 91)
LDL (mmol/L)* 2.0 (1.6, 2.6)
HDL (mmol/L)* 1.12 (0.94, 1.38)
Triglycerides (mmol/L)* 1.42 (1.06, 1.91)
HbA1c (%)* 7.4 (6.8, 8.3)
Glucose (mmol/L)* 8.1 (6.9, 9.8)
Insulin (pmol/L)* 57 (33, 102)
C-peptide (pmol/L)* 965 (713, 1290)
HOMA2-IR* 1.3 (0.7, 2.1)
Anti-platelet therapy 129 (94%)
Statin 128 (93%)
Beta-blocker 106 (77%)
ACE-inhibitor/ARB 96 (70%)
Metformin 101 (74%)
Sulfonylurea 47 (34%)
Gliptin 17 (12%)
Insulin/insulin-analogue 26 (19%)
  1. Data presented as proportions or mean value ± SD if not otherwise stated.
  2. ACE; angiotensin converting enzyme. ARB; angiotensin receptor blocker.
  3. *Median (25, 75 percentiles). ¤International Diabetes Federation, 2006.